Systematic review and meta-analysis indicates modest ABO blood group influence on SARS-CoV-2 susceptibility in Saudi Arabia.
Although previous studies and meta-analyses have suggested modest and population-dependent associations between ABO blood groups and susceptibility to SARS-CoV-2 infection, findings have remained inconsistent across different geographic regions. We synthesized data from nine studies conducted in Saudi Arabia between 2020 and 2024 to define national patterns. Eight datasets with extractable data contributed 7,650 laboratory-confirmed cases to quantitative analyses. Group O accounted for the largest proportion of infections (random effects estimate 41.7%, 95% CI 38.0-45.6), followed by group A (27.8%, 95% CI 25.6-29.9) and group B (21.2%, 95% CI 18.0-24.6). Group AB represented the smallest fraction (6.4%, 95% CI 3.7-9.9). Substantial heterogeneity was observed across all blood groups (I² 72.1-96.5%) yet leave-one-out analyses confirmed stable pooled estimates. Statistical assessments provided no evidence of publication bias. The pooled distributions closely mirrored background ABO frequencies in the Saudi population, indicating that ABO-related differences in infection susceptibility are modest relative to epidemiologic and demographic factors.
No takes yet. Share an insight, caveat, or question.
Alenzi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: